COVID-19 Variants

Even after the initial pandemic wave, COVID-19 remains a dynamic global concern due to the emergence of new variants. Variants such as Delta, Omicron, and their sub-lineages have exhibited changes in transmissibility, immune escape, and disease severity. These mutations challenge vaccine efficacy and public health responses, highlighting the need for ongoing genomic surveillance and adaptive strategies. This session will cover the latest findings on SARS-CoV-2 evolution, global variant tracking, booster vaccine development, and long COVID impacts. Attendees will learn about how public health systems have adapted to the variant era and what lessons apply to future outbreaks. By understanding how COVID-19 continues to evolve, researchers and policymakers can refine strategies for response, treatment, and communication in a post-pandemic world.

    Related Conference of COVID-19 Variants

    August 28-29, 2025

    8th Pathology and Infectious Disease Conference

    London, UK
    September 22-23, 2025

    11th International Conference on Infectious and Rare Diseases

    Vancouver, Canada
    December 11-12, 2025

    8th Annual Congress on Bacterial, Viral and Infectious Diseases

    Prague, Czech Republic
    December 15-16, 2025

    7th Global Experts Meeting on Infectious Diseases

    Barcelona, Spain
    December 17-18, 2025

    17th Global Conference on Nephrology and Infectious Diseases

    Amsterdam, Netherlands
    May 18-19, 2026

    15th World Congress on Rare Diseases and Orphan Drugs

    Prague, Czech Republic

    COVID-19 Variants Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in